| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Sep'17 | Jun'17 |
|---|---|---|---|---|---|---|---|---|---|---|
Operating expenses: | ||||||||||
Research and development | ||||||||||
28,893 | 27,363 | 24,604 | 22,188 | 20,491 | 18,136 | 15,021 | 11,802 | 0 | 0 | 0 |
General and administrative | ||||||||||
10,618 | 9,979 | 9,167 | 8,166 | 7,458 | 6,590 | 5,471 | 4,307 | 0 | 0 | 0 |
Total operating expenses | ||||||||||
39,511 | 37,342 | 33,771 | 30,354 | 27,949 | 24,726 | 20,492 | 16,109 | 0 | 0 | 0 |
Loss from operations | ||||||||||
-39,511 | -37,342 | -33,771 | -30,354 | -27,949 | -24,726 | -20,492 | -16,109 | 0 | 0 | 0 |
Interest income | ||||||||||
2,054 | 2,255 | 2,481 | 2,549 | 2,087 | 1,559 | 1,027 | 427 | 0 | 0 | 0 |
Net loss | ||||||||||
-37,457 | -35,087 | -31,290 | -27,805 | -25,862 | -23,167 | -19,465 | -15,682 | 0 | 0 | 0 |
Net loss per common share, basic and diluted | ||||||||||
-0.30 | -0.50 | -0.48 | -0.46 | -0.40 | 7.88 | -0.30 | -3.31 | -6.53 | -3.31 | -3.30 |
Weighted-average shares used to compute net loss per common share, basic and diluted | ||||||||||
32,867 | 19,123 | 19,095 | 19,073 | 19,042 | 19,301 | 18,955 | 2,044 | 757 | 628 | 569 |